#GreenTea

Groundbreaking laboratory research from the University of California Irvine demonstrates that combining vitamin B3 with green tea extract can restore youthful energy balance in aging mouse brain cells within 16-24 hours, potentially clearing Alzheimer’s-associated protein deposits and revitalizing cellular cleanup systems. The study, published in GeroScience, reveals that specific aspects of neuronal aging may be surprisingly reversible at the cellular level, offering hope for Thailand’s rapidly expanding elderly population facing escalating dementia risks. However, leading researchers emphasize critical limitations: these remarkable effects occurred only in laboratory dish conditions, have not been tested in living animals or humans, and face significant challenges in dosage, delivery, and safety that must be resolved before any therapeutic applications emerge.

A lab study from the University of California, Irvine reports that a simple combination of nicotinamide (a form of vitamin B3) and EGCG, the antioxidant in green tea, restored “youthful” energy balance in aging mouse neurons and helped clear Alzheimer’s‑linked protein clumps within 16–24 hours. The work, published in the journal GeroScience, suggests that some aspects of brain cell aging may be surprisingly reversible — at least in a dish — but experts caution that the findings have not yet been tested in living animals or people, and that dosing, delivery and safety remain open questions (GeroScience, Springer; PubMed; UC Irvine news; StudyFinds summary).

Scientists at the University of California, Irvine have achieved a remarkable breakthrough that could revolutionize brain health for Thailand’s rapidly aging population, demonstrating that two everyday nutritional compounds can literally reverse cellular aging in damaged brain tissue within mere hours of treatment. The extraordinary research, published in the prestigious journal GeroScience, reveals how vitamin B3 combined with green tea extract can restore youthful energy production and waste-clearing mechanisms to severely deteriorated neurons, offering transformative hope for the estimated 600,000 Thai families currently struggling with dementia-related challenges. This discovery carries profound implications for Thailand’s healthcare future, where dementia cases are expected to reach nearly two million by 2030 as the kingdom experiences one of the world’s fastest population aging rates, creating urgent demand for accessible, scientifically-proven intervention strategies that can be implemented before cognitive decline becomes irreversible.

A pioneering study from the University of California, Irvine, has revealed that a combination of vitamin B3 (nicotinamide) and the key green tea antioxidant EGCG could quickly restore youthful function to aging brain cells — at least in a laboratory setting — sparking hope for future therapies addressing cognitive decline and Alzheimer’s disease. The findings, published in the journal GeroScience, have captured international attention, including in Thailand, where dementia prevalence continues to rise and natural preventive approaches are increasingly sought after (studyfinds.org).

Green tea, long celebrated in Asian cultures and increasingly popular in Thailand, continues to capture global attention for its wide-ranging health benefits. New research supported by nutritionists and prominent institutions underscores green tea’s potential to positively impact heart health, support cognitive function, and contribute to overall wellness—though evidence remains mixed on some health claims.

For centuries, green tea has been a staple in Thai communities, often enjoyed hot or iced, blending well with local traditions. The recent surge in scientific investigations has added weight to the beverage’s revered medicinal reputation. A review published by the US National Institutes of Health noted that polyphenolic compounds in green tea—particularly catechins—are associated with beneficial effects in prevention of cardiovascular disease, though these findings must still be interpreted with caution due to limitations in the available data (PMC4055352). Another comprehensive review pointed to possible protective effects against a range of ailments, including certain cancers, liver disorders, and heart conditions, but emphasized that most of the results stem from laboratory research or observational studies—not definitive clinical trials (PMC2855614).